Scarica l'app Stockscreener
111.74
0.59%
0.65
Dopo l'orario di chiusura:
111.92
0.18
+0.16%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$111.09
Aprire:
$111.265
Volume 24 ore:
10.25M
Relative Volume:
0.81
Capitalizzazione di mercato:
$199.93B
Reddito:
$169.71B
Utile/perdita netta:
$14.65B
Rapporto P/E:
15.71
EPS:
7.1125
Flusso di cassa netto:
$25.64B
1 W Prestazione:
+3.66%
1M Prestazione:
+10.90%
6M Prestazione:
+42.56%
1 anno Prestazione:
+55.28%
Intervallo 1D:
$111.11
$112.34
Intervallo di 1 settimana:
$107.01
$112.34
Portata 52W:
$55.51
$112.34
Citigroup Inc Stock (C) Company Profile
Nome
Citigroup Inc
Settore
Industria
Telefono
(212) 559-1000
Indirizzo
388 GREENWICH STREET, NEW YORK, NY
Confronta C con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
C
Citigroup Inc
|
111.74 | 198.77B | 169.71B | 14.65B | 25.64B | 7.1125 |
|
JPM
Jpmorgan Chase Co
|
317.38 | 844.20B | 277.72B | 57.74B | 45.88B | 20.19 |
|
BAC
Bank Of America Corp
|
54.56 | 394.92B | 195.86B | 29.65B | 42.62B | 3.6688 |
|
WFC
Wells Fargo Co
|
92.59 | 284.68B | 123.07B | 21.20B | 35.82B | 6.0712 |
|
HSBC
Hsbc Holdings Plc Adr
|
75.24 | 254.33B | 138.28B | 17.44B | 105.99B | 4.7081 |
|
RY
Royal Bank Of Canada
|
167.02 | 231.23B | 97.16B | 14.56B | 14.01B | 10.06 |
Citigroup Inc Stock (C) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-05-15 | Iniziato | TD Cowen | Hold |
| 2025-01-06 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2024-12-03 | Aggiornamento | Keefe Bruyette | Mkt Perform → Outperform |
| 2024-04-04 | Reiterato | Evercore ISI | In-line |
| 2024-03-25 | Reiterato | Wells Fargo | Overweight |
| 2024-03-14 | Aggiornamento | Goldman | Neutral → Buy |
| 2024-02-14 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2024-01-30 | Aggiornamento | Morgan Stanley | Underweight → Overweight |
| 2024-01-10 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| 2024-01-09 | Aggiornamento | HSBC Securities | Hold → Buy |
| 2024-01-08 | Downgrade | Societe Generale | Hold → Sell |
| 2024-01-03 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2023-12-18 | Aggiornamento | Daiwa Securities | Neutral → Buy |
| 2023-09-07 | Iniziato | HSBC Securities | Hold |
| 2023-07-18 | Aggiornamento | Odeon | Hold → Buy |
| 2023-07-10 | Downgrade | Societe Generale | Buy → Hold |
| 2022-12-08 | Iniziato | Piper Sandler | Neutral |
| 2022-10-03 | Downgrade | Goldman | Buy → Neutral |
| 2022-09-06 | Downgrade | Odeon | Buy → Hold |
| 2022-05-27 | Downgrade | Credit Suisse | Outperform → Neutral |
| 2022-03-28 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| 2022-03-07 | Downgrade | Jefferies | Buy → Hold |
| 2022-03-03 | Downgrade | Atlantic Equities | Overweight → Neutral |
| 2022-03-03 | Downgrade | Keefe Bruyette | Outperform → Mkt Perform |
| 2021-12-15 | Aggiornamento | Odeon | Hold → Buy |
| 2021-12-10 | Ripresa | UBS | Neutral |
| 2021-12-06 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2021-07-07 | Ripresa | Keefe Bruyette | Outperform |
| 2021-06-16 | Reiterato | Credit Suisse | Outperform |
| 2021-04-05 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2021-03-29 | Downgrade | Edward Jones | Buy → Hold |
| 2021-01-21 | Downgrade | Berenberg | Buy → Hold |
| 2021-01-06 | Iniziato | Daiwa Securities | Buy |
| 2021-01-04 | Downgrade | Barclays | Overweight → Equal Weight |
| 2020-11-19 | Aggiornamento | Keefe Bruyette | Mkt Perform → Outperform |
| 2020-10-15 | Downgrade | DZ Bank | Buy → Hold |
| 2020-10-08 | Downgrade | JP Morgan | Overweight → Neutral |
| 2020-08-18 | Downgrade | Odeon | Hold → Sell |
| 2020-07-17 | Downgrade | Odeon | Buy → Hold |
| 2020-07-08 | Iniziato | Seaport Global Securities | Buy |
| 2020-07-07 | Aggiornamento | Societe Generale | Hold → Buy |
| 2020-06-09 | Downgrade | Standpoint Research | Buy → Hold |
| 2020-06-02 | Aggiornamento | Odeon | Hold → Buy |
| 2020-05-18 | Aggiornamento | Standpoint Research | Hold → Buy |
| 2020-04-20 | Aggiornamento | Argus | Hold → Buy |
| 2020-04-14 | Aggiornamento | Societe Generale | Sell → Hold |
| 2020-04-01 | Downgrade | Keefe Bruyette | Outperform → Mkt Perform |
| 2020-02-03 | Downgrade | Odeon | Buy → Hold |
| 2020-01-09 | Iniziato | DA Davidson | Buy |
| 2020-01-06 | Downgrade | Deutsche Bank | Buy → Hold |
| 2020-01-06 | Reiterato | Goldman | Buy |
| 2019-07-26 | Aggiornamento | Keefe Bruyette | Mkt Perform → Outperform |
| 2019-05-30 | Aggiornamento | Goldman | Neutral → Buy |
| 2019-02-22 | Aggiornamento | Jefferies | Hold → Buy |
Mostra tutto
Citigroup Inc Borsa (C) Ultime notizie
Mexico is close to approving Citi's sale of Banamex stakereport (C:NYSE) - Seeking Alpha
Citigroup Lowers Price Target for United Rentals (URI) to $950 | - GuruFocus
Citigroup Raises Halliburton (HAL) Price Target Amid 'Buy' Ratin - GuruFocus
GKOS: Citigroup Raises Glaukos Price Target to $125, Maintains B - GuruFocus
Stryker (SYK) Price Target Lowered by Citigroup Analyst | SYK St - GuruFocus
Citigroup Maintains Neutral Rating on TOL, Lowers Price Target | TOL Stock News - GuruFocus
Mexico Nears Approval of Billionaire’s Bid for Banamex Stake - Bloomberg.com
CNH: Citigroup Maintains Rating but Lowers Price Target | CNH St - GuruFocus
Citigroup Raises Price Target for Cummins (CMI) to USD 580 | CMI Stock News - GuruFocus
EW Stock Sees Price Target Boost from Citigroup, Maintains Buy R - GuruFocus
DexCom (DXCM) Sees Buy Rating Maintained by Citigroup with Price - GuruFocus
Penumbra Shares Rise After Citigroup Upgrade - marketscreener.com
Bausch + Lomb Shares Rise After Citigroup Upgrade - marketscreener.com
Key facts: Citigroup embraces cryptocurrency; forecasts Fed rate cuts - TradingView
Is Citigroup Stock a Buy Now? - AOL.com
Citigroup (C) Valuation Check After New Preferred Stock, Strong Results and Upbeat 2025 Income Outlook - Yahoo Finance
Citigroup stock hits 52-week high at 111.92 USD By Investing.com - Investing.com Canada
Citigroup stock hits 52-week high at 111.92 USD - Investing.com
WHD: Cactus Upgraded to Buy by Citigroup, Price Target Raised to $55 | WHD Stock News - GuruFocus
Citigroup Upgrades Thermo Fisher Scientific (TMO), Raises Price Target | TMO Stock News - GuruFocus
Citigroup Downgrades QGEN, Lowers Price Target to $50.00 | QGEN Stock News - GuruFocus
What Citigroup (C)'s Preferred Stock Reset and Funding Moves Mean for Shareholders - simplywall.st
Intuitive Surgical (ISRG) Sees Downgrade by Citigroup with PT Ad - GuruFocus
Haemonetics (HAE) Downgraded to Neutral by Citigroup, Raises Pri - GuruFocus
Glenview Trust co Grows Position in Citigroup Inc. $C - MarketBeat
Citigroup Upgrades Fortrea Holdings to Buy From Neutral - marketscreener.com
Citigroup Upgrades Bausch + Lomb to Buy From Neutral, Adjusts Price Target to $20 From $16 - marketscreener.com
Citigroup Downgrades QGEN to Neutral From Buy, Price Target is $55 - marketscreener.com
Sei Investments Co. Sells 19,002 Shares of Citigroup Inc. $C - MarketBeat
Analysts Offer Insights on Financial Companies: First Horizon (FHN), Citigroup (C) and Affiliated Managers (AMG) - The Globe and Mail
Citigroup Adjusts AutoZone Price Target to $4,200 From $4,775, Maintains Buy Rating - marketscreener.com
Citigroup Adjusts Edwards Lifesciences Price Target to $101 From $96, Maintains Buy Rating - marketscreener.com
Citigroup Adjusts Las Vegas Sands Price Target to $76.75 From $75.50, Maintains Buy Rating - marketscreener.com
Citigroup Adjusts Stryker Price Target to $420 From $455, Maintains Buy Rating - marketscreener.com
Citigroup Adjusts PT on GE Healthcare Technologies to $88 From $83, Maintains Neutral Rating - marketscreener.com
Citigroup Adjusts Price Target on Zimmer Biomet Holdings to $94 From $98, Maintains Neutral Rating - marketscreener.com
Citigroup Adjusts Price Target on Oracle to $370 From $375, Maintains Buy Rating - marketscreener.com
Piper Sandler Keeps Their Buy Rating on Citigroup (C) - The Globe and Mail
Citigroup Downgrades Intuitive Surgical to Neutral From Buy, Adjusts Price Target to $635 From $650 - marketscreener.com
Citigroup Adjusts Price Target on Johnson & Johnson to $232 From $215, Maintains Buy Rating - marketscreener.com
CME Group fines Citigroup Global Markets for alleged CBOT rule violation - FX News Group
Citigroup Raises Price Target for Elkem to 30 Norwegian Kroner, Reiterates Neutral RatingBN - marketscreener.com
Citigroup Upgrades H&M to Neutral (Sell), Sets Target Price at 172 KronorBN - marketscreener.com
Citigroup Downgrades Evolution to Neutral (Buy), Target Price Set at 630 SEKBN - marketscreener.com
Citigroup (C) Beats Stock Market Upswing: What Investors Need to Know - Yahoo Finance Singapore
Citi Lowers Base Rate - marketscreener.com
Citigroup Establishes New Series of Preferred Stock - TipRanks
Citigroup Inc. (C) Announces New Series of Preferred Stock - GuruFocus
Form 424B2 CITIGROUP INC - StreetInsider
Citigroup Maintains Neutral Rating on XOM, Raises Price Target t - GuruFocus
Citigroup Raises Price Target on Knight-Swift (KNX) to $59.00 | - GuruFocus
Citigroup Inc Azioni (C) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.95%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):